MORC3 and dermatomyositis: CD16+ Mo increased in the anti‐NXP2 group (6.32% vs. 1.29% in NC), whereas ISGhi Mo increased across all DM antibody subgroups, with the highest levels in the anti‐NXP2 group (10.21% vs. 0% in NC).